已发表论文

原儿茶醛治疗糖尿病性白内障分子机制的网络药理学研究

 

Authors Cheng X, Song Z, Wang X, Xu S, Dong L, Bai J, Li G, Zhang C

Received 18 August 2021

Accepted for publication 17 September 2021

Published 23 September 2021 Volume 2021:15 Pages 4011—4023

DOI https://doi.org/10.2147/DDDT.S334693

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Tuo Deng

Purpose: Protocatechualdehyde (PCA) is a phenolic compound found in the roots of Salvia miltiorrhiza  with anti-proliferative and antioxidant activities. At present, there are few studies on protocatechualdehyde against diabetic cataract (DC), and there is also lack of systematic research on the mechanism of protocatechualdehyde. Therefore, this study tried to comprehensively clarify the targets and complex mechanisms of PCA against DC from the perspective of network pharmacology.
Materials and Methods: Through collecting relevant targets from the databases, GO and KEGG enrichment analysis were performed on the potential targets. Moreover, core genes were identified by topological analysis of protein–protein interaction (PPI) network and gene–phenotype correlation analysis.
Results: The results indicated that protocatechualdehyde may be closely related to targets such as AKT1, MAPK3 and HDAC3, as well as signal pathways such as MAPK signaling pathway, PI3K-Akt signaling pathway and AGE-RAGE signaling pathway in diabetic complications.
Conclusion: Together, the present study systematically clarified the possible mechanisms of protocatechualdehyde in the treatment of diabetic cataract and provided new ideas for the drug research of this disease.
Keywords: protocatechualdehyde, diabetic cataract, network pharmacology, topological analysis, gene–phenotype correlation analysis